Imaging of metabolic bone diseases

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 6, 2008, Pages 1127-1139

  Haugeberg, Glenn ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Sørlandet Hospital   (Norway)

Author keywords

bone scintigraphy; CT; DEXA; DXR; imaging; metabolic bone diseases; MRI; osteomalacia; osteoporosis; Paget's disease; ultrasonography

Indexed keywords

BONE DENSITY; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE STRENGTH; CLINICAL ASSESSMENT; DEVICE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FRACTURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; METABOLIC BONE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; DIAGNOSTIC IMAGING; HUMANS; OSTEITIS DEFORMANS; OSTEOMALACIA; OSTEOPOROSIS; RADIONUCLIDE IMAGING;

EID: 56549129585     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.09.016     Document Type: Review

References (97)

1. Sambrook P.N., Hughes D.R., Nelson A.E., et al. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the Rheumatic Diseases 62 (2003) 1215-1217
2. Lane N.E., Yao W., Balooch M., et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. Journal of Bone and Mineral Research 21 (2006) 466-476
3. Jørgensen J.T., Andersen P.B., Rosholm A., and Hannover Bjarnason N. Digital x-ray radiogrammetry: a new appendicular bone densitometric method with high precision. Clinical Physiology 20 (2000) 330-335
4. Blake G.M., and Fogelman I. Technical principles of dual energy x-ray absorptiometry. Seminars In Nuclear Medicine 27 (1997) 210-228
5. Njeh C.F., Fuerst T., Diessel E., and Genant H.K. Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporosis International 12 (2001) 1-15
6. Cann C.E. Quantitative CT for determination of bone mineral density: a review. Radiology 166 (1988) 509-522
7. Jesserer H., Zita G., and Drexler H. Bone scintigraphy in osteodystrophia deformans (Paget's disease). Fortschritte der Medizin 95 (1977) 2451-2458
8. Fogelman I., Carr D., and Boyle I.T. The role of bone scanning in Paget's disease. Metabolic Bone Disease & Related Research 3 (1981) 243-254
9. Vellenga C.J., Bijvoet O.L., and Pauwels E.K. Bone scintigraphy and radiology in Paget's disease of bone: a review. American Journal of Physiologic Imaging 3 (1988) 154-168
10. Alvarez L., Peris P., Guanabens N., et al. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment. Rheumatology (Oxford) 43 (2004) 869-874
11. Fogelman I., and Carr D. A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease. European Journal of Nuclear Medicine 5 (1980) 417-421
12. Pons F., Alvarez L., Peris P., et al. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity. Nuclear Medicine Communications 20 (1999) 525-528
13. Peris P., Alvarez L., Vidal S., et al. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy. Clinical and Experimental Rheumatology 25 (2007) 206-210
14. Ang G., Feiglin D., and Moses A.M. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels. Endocrine Practice 9 (2003) 280-283
15. Oesterreich F.U., Heller M., Triebel H.J., and Kruse H.P. Morphology of Paget's osteodystrophia deformans in the computed tomogram. Rofo 149 (1988) 603-608
16. Trumble T.E., Wu R.K., and Ruwe P.A. Paget's disease in the hand: correlation of magnetic resonance imaging with histology. The Journal of Hand Surgery[Am] 15 (1990) 504-507
17. Vuillemin-Bodaghi V., Parlier-Cuau C., Cywiner-Golenzer C., et al. Multifocal osteogenic sarcoma in Paget's disease. Skeletal Radiology 29 (2000) 349-353
18. Seret P., Basle M.F., Rebel A., et al. Sarcomatous degeneration in Paget's bone disease. Journal of Cancer Research and Clinical Oncology 113 (1987) 392-399
19. Fransen P., Mestdagh C., and Dardenne G. Pagetic sarcoma of the calvarium: report of two cases. Acta Neurologica Belgica 98 (1998) 352-355
20. Fogelman I., McKillop J.H., Bessent R.G., et al. The role of bone scanning in osteomalacia. Journal of Nuclear Medicine 19 (1978) 245-248
21. Fogelman I., McKillop J.H., Greig W.R., and Boyle I.T. Pseudofracture of the ribs detected by bone scanning. Journal of Nuclear Medicine 18 (1977) 1236-1237
22. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. American Journal of Medicine 94 (1993) 646-650
23. Haugeberg G., Uhlig T., Falch J.A., et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis & Rheumatism 43 (2000) 522-530
24. Gough A.K., Lilley J., Eyre S., et al. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344 (1994) 23-27
25. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341 (1993) 72-75
26. Legrand E., Chappard D., Pascaretti C., et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. Journal of Bone and Mineral Research 15 (2000) 13-19
27. Crabtree N.J., Kroger H., Martin A., et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporosis International 13 (2002) 48-54
28. Laan R.F., van Riel P.L., and van de Putte L.B. Bone mass in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 51 (1992) 826-832
29. Rosholm A., Hyldstrup L., Baeksgaard L., et al. Estimation of bone mineral density by digital x-ray radiogrammetry: theoretical background and clinical testing. Osteoporosis International 12 (2001) 961-969
30. Johnell O., Onnby K., and Redlund-Johnell I. Superior short-term in vivo precision with digital x-ray radiogrammetry compared to DXA. Journal of Bone and Mineral Research 15 Suppl. 1 (2000) SU280
31. Sambrook P., Raj A., Hunter D., et al. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. The Journal of Rheumatology 28 (2001) 1063-1067
32. Blanckaert F., Cortet B., Coquerelle P., et al. Contribution of calcaneal ultrasonic assessment to the evaluation of postmenopausal and glucocorticoid-induced osteoporosis. Revue du Rhumatisme (English ed.) 64 (1997) 305-313
33. Bonnick S.L., Johnston Jr. C.C., Kleerekoper M., et al. Importance of precision in bone density measurements. Journal of Clinical Densitometry 4 (2001) 105-110
34. Kanis J.A., Delmas P., Burckhardt P., et al. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporosis International 7 (1997) 390-406
35. Kanis J.A., Melton L.J., Christiansen C., et al. The diagnosis of osteoporosis. [see comments]. Journal of Bone and Mineral Research 9 (1994) 1137-1141
36. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994), World Health Organization, Geneva
37. Chen Z., Maricic M., Lund P., et al. How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporosis International 8 (1998) 423-427
38. Looker A.C., Orwoll E.S., Johnston C.C., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. Journal of Bone and Mineral Research 12 (1997) 1761-1768
39. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporosis International 8 (1998) 468-489
40. Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone 2008; 42: 467-475. Available from: .
41. Kanis J.A., and Gluer C.C. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporosis International 11 (2000) 192-202
42. Binkley N., Bilezikian J.P., Kendler D.L., et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. Journal of Clinical Densitometry 9 (2006) 4-14
43. Binkley N., and Krueger D. Osteoporosis in men. WMJ 101 (2002) 28-32
44. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
45. Haugeberg G., Green M.J., Conaghan P.G., et al. Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 66 (2007) 1513-1517
46. Cullum I.D., Ell P.J., and Ryder J.P. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. British Journal of Radiology 62 (1989) 587-592
47. Johnson J., and Dawson-Hughes B. Precision and stability of dual-energy X-ray absorptiometry measurements. Calcified Tissue International 49 (1991) 174-178
48. LeBlanc A.D., Schneider V.S., Engelbretson D.A., and Evans H.J. Precision of regional bone mineral measurements obtained from total-body scans. Journal of Nuclear Medicine 31 (1990) 43-45
49. Kelly T.L., Slovik D.M., and Neer R.M. Calibration and standardization of bone mineral densitometers. Journal of Bone and Mineral Research 4 (1989) 663-669
50. Laskey M.A., Flaxman M.E., Barber R.W., et al. Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers. British Journal of Radiology 64 (1991) 1023-1029
51. Lewis M.K., Blake G.M., and Fogelman I. Patient dose in dual x-ray absorptiometry. Osteoporosis International 4 (1994) 11-15
52. Laan R.F., van Riel P.L., van de Putte L.B., et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Annals of Internal Medicine 119 (1993) 963-968
53. Lane N.E., Sanchez S., Modin G.W., et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. The Journal of Clinical Investigation 102 (1998) 1627-1633
54. Rehman Q., Lang T., Modin G., and Lane N.E. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis & Rheumatism 46 (2002) 1292-1297
55. Patel R., Blake G.M., and Fogelman I. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Calcified Tissue International 80 (2007) 89-96
56. Blake G.M., Chinn D.J., Steel S.A., et al. A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporosis International 16 (2005) 2149-2156
57. Patel R., Blake G.M., and Fogelman I. An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry. Osteoporosis International 15 (2004) 497-504
58. Barnett E., and Nordin B. The radiological diagnosis of osteoporosis: a new approach. Clinical Radiology 11 (1960) 166-174
59. Hyldstrup L., and Nielsen S.P. Metacarpal index by digital X-ray radiogrammetry: normative reference values and comparison with dual X-ray absorptiometry. Journal of Clinical Densitometry 4 (2001) 299-306
60. Nielsen S.P. The metacarpal index revisited: a brief overview. Journal of Clinical Densitometry 4 (2001) 199-207
61. Hyldstrup L., Jorgensen J.T., Sorensen T.K., and Baeksgaard L. Response of cortical bone to antiresorptive treatment. Calcified Tissue International 68 (2001) 135-139
62. Boonen S., Nijs J., Borghs H., et al. Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study. Osteoporosis International 16 (2005) 93-100
63. Reed M.R., Murray J.R., Abdy S.E., et al. The use of digital X-ray radiogrammetry and peripheral dual energy X-ray absorptiometry in patients attending fracture clinic after distal forearm fracture. Bone 34 (2004) 716-719
64. Bouxsein M.L., Palermo L., Yeung C., and Black D.M. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporosis International 13 (2002) 358-365
65. Bottcher J., Pfeil A., Mentzel H., et al. Peripheral bone status in rheumatoid arthritis evaluated by digital X-ray radiogrammetry and compared with multisite quantitative ultrasound. Calcified Tissue International 78 (2006) 25-34
66. Haugeberg G., Lodder M.C., Lems W.F., et al. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross-sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Annals of the Rheumatic Diseases 63 (2004) 1331-1334
67. Barkmann R., Laugier P., Moser U., et al. A method for the estimation of femoral bone mineral density from variables of ultrasound transmission through the human femur. Bone 40 (2007) 37-44
68. Dencks S., Barkmann R., Padilla F., et al. Wavelet-based signal processing of in vitro ultrasonic measurements at the proximal femur. Ultrasound In Medicine and Biology 33 (2007) 970-980
69. Stewart A., Felsenberg D., Eastell R., et al. Relationship between risk factors and QUS in a European population: the OPUS study. Bone 39 (2006) 609-615
70. Gluer C.C., Eastell R., Reid D.M., et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. Journal of Bone and Mineral Research 19 (2004) 782-793
71. Gluer C.C. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. Journal of Bone and Mineral Research 12 (1997) 1280-1288
72. Huopio J., Kroger H., Honkanen R., et al. Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporosis International 15 (2004) 190-195
73. Hans D., Schott A.M., Duboeuf F., et al. Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone 35 (2004) 357-363
74. Fujiwara S., Sone T., Yamazaki K., et al. Heel bone ultrasound predicts non-spine fracture in Japanese men and women. Osteoporosis International 16 (2005) 2107-2112
75. Bauer D.C., Ewing S.K., Cauley J.A., et al. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporosis International 18 (2007) 771-777
76. Krieg M.A., Cornuz J., Ruffieux C., et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or = 70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. Journal of Bone and Mineral Research 21 (2006) 1457-1463
77. Hans D., Srivastav S.K., Singal C., et al. Does combining the results from multiple bone sites measured by a new quantitative ultrasound device improve discrimination of hip fracture?. Journal of Bone and Mineral Research 14 (1999) 644-651
78. Gluer C.C., Wu C.Y., and Genant H.K. Broadband ultrasound attenuation signals depend on trabecular orientation: an in vitro study. Osteoporosis International 3 (1993) 185-191
79. Gluer C.C., Wu C.Y., Jergas M., et al. Three quantitative ultrasound parameters reflect bone structure. Calcified Tissue International 55 (1994) 46-52
80. Daens S., Peretz A., de M V., Moris M., and Bergmann P. Efficiency of quantitative ultrasound measurements as compared with dual-energy X-ray absorptiometry in the assessment of corticosteroid-induced bone impairment. Osteoporosis International 10 (1999) 278-283
81. Peel N.F., Moore D.J., Barrington N.A., et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Annals of the Rheumatic Diseases 54 (1995) 801-806
82. Luengo M., Picado C., Del Rio L., et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46 (1991) 803-806
83. Naganathan V., Jones G., Nash P., et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Archives of Internal Medicine 160 (2000) 2917-2922
84. Selby P.L., Halsey J.P., Adams K.R., et al. Corticosteroids do not alter the threshold for vertebral fracture. Journal of Bone and Mineral Research 15 (2000) 952-956
85. Cheng S., Fan B., Wang L., et al. Ultrasound and bone mineral density assessments of the calcaneus in people with various musculoskeletal conditions. Bone 23 Suppl. (1998) S458
86. Martin J.C., Munro R., Campbell M.K., and Reid D.M. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. British Journal of Rheumatology 36 (1997) 43-49
87. Haugeberg G., Orstavik R.E., Uhlig T., et al. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporosis International 14 (2003) 312-319
88. Fogelman I., and Carr D. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clinical Radiology 31 (1980) 321-326
89. Spitz J., Lauer I., Tittel K., and Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. Journal of Nuclear Medicine 34 (1993) 1403-1409
90. Laib A., Beuf O., Issever A., et al. Direct measures of trabecular bone architecture from MR images. Advances In Experimental Medicine and Biology 496 (2001) 37-46
91. Borah B., Gross G.J., Dufresne T.E., et al. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anatomical Record 265 (2001) 101-110
92. Ladinsky G.A., and Wehrli F.W. Noninvasive assessment of bone microarchitecture by MRI. Current Osteoporosis Reports 4 (2006) 140-147
93. Carballido-Gamio J., and Majumdar S. Clinical utility of microarchitecture measurements of trabecular bone. Current Osteoporosis Reports 4 (2006) 64-70
94. Lespessailles E., Chappard C., Bonnet N., and Benhamou C.L. Imaging techniques for evaluating bone microarchitecture. Joint Bone Spine 73 (2006) 254-261
95. Bauer J.S., Link T.M., Burghardt A., et al. Analysis of trabecular bone structure with multidetector spiral computed tomography in a simulated soft-tissue environment. Calcified Tissue International 80 (2007) 366-373
96. Krug R., Carballido-Gamio J., Burghardt A.J., et al. Wavelet-based characterization of vertebral trabecular bone structure from magnetic resonance images at 3 T compared with micro-computed tomographic measurements. Magnetic Resonance in Imaging 25 (2007) 392-398
97. Graeff C., Timm W., Nickelsen T.N., et al. Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study. Journal of Bone and Mineral Research 22 (2007) 1426-1433